Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Achillion Pharmaceuticals, Inc. (NQ: ACHN)
7.580 USD  -0.060 (-0.79%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 24, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about Achillion Pharmaceuticals, Inc.
 
< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Brean Murray Carret & Co. Starts Achillion Pharmaceuticals (ACHN) at Buy, $9 Pirce Target
June 02, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6555116 for the full story. Read More
from StreetInsider.com News Articles
ThinkEquity Starts Achillion Pharmaceuticals (ACHN) at Buy
June 02, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6554789 for the full story. Read More
from StreetInsider.com News Articles
New Ratings (ACHN, ANDS, DNDN, EXPR, IDIX, INCY, INHX, MTL, VRUS, QLTY, RLD, RRTS, STIR)
June 02, 2011
New York, June 2nd (TradersHuddle.com) – Following are some of the new analyst ratings before the market open. Research Firms Initiate: Achillion Pharmaceuticals . Read More -- Read More
from TradersHuddle.com
William Blair Starts Achillion Pharmaceuticals (ACHN) at Outperform
May 26, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6540063 for the full story. Read More
from StreetInsider.com News Articles
Achillion (ACHN) Begins Phase 1 Trial of ACH-2684 for the Treatment of Hepatitis C
May 25, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6536430 for the full story. Read More
from StreetInsider.com News Articles
Achillion Announces Initiation of Phase 1 Trial of ACH-2684 for the Treatment of Hepatitis C
May 25, 2011
First-in-Human Trial Will Evaluate Safety of Pan-Genotypic Protease Inhibitor in Both Healthy Subjects and Genotype 1 or 3 HCV-Infected Patients Read More
from GlobeNewswire News Releases
Achillion to Present at Two Upcoming Investor Conferences
May 20, 2011
from GlobeNewswire News Releases
Achillion Added to the NASDAQ Biotechnology Index (NBI)
May 18, 2011
from GlobeNewswire News Releases
Roth Capital Starts Achillion Pharmaceuticals (ACHN) at Buy
May 12, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6497936 for the full story. Read More
from StreetInsider.com News Articles
Achillion Pharmaceuticals (ACHN) Reports Q1 EPS Loss of $0.17
May 04, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6470544 for the full story. Read More
from StreetInsider.com News Articles
Achillion Reports First Quarter 2011 Financial Results
May 04, 2011
from GlobeNewswire News Releases
Achillion’s Pipeline Progresses
April 16, 2011
Recently, Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) announced that it has started dosing patients in a randomized, double-blind mid-stage study (n~120) that will evaluate pipeline candidate... Read More
category RHHBY , VRX , External Research , and 8 more.
from DailyMarkets.com
Achillion to Present at Upcoming Investor Conferences
April 08, 2011
from GlobeNewswire News Releases
Positive Drug Data Prompts Call Activity on Achillion Pharmaceuticals
March 30, 2011
Achillion Pharmaceuticals, Inc. (ACHN - 7.18) skyrocketed to a new multi-year high of %247.50 today, after the firm announced positive mid-stage trial results for its chronic hepatitis C treatment...(... Read More
category ACHN
from SchaeffersResearch.com Daily Market Blog
ADP data, Apollo Global, Cephalon in focus
March 30, 2011
U.S. stock futures shave earlier gains in the wake of the latest ADP report on private-sector payrolls. Read More
category Earnings , Biotechnology , VRX , and 25 more.
from MarketWatch
Achillion (ACHN) Reports Top-Line Results for ACH-1625 Phase 2a
March 30, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6395743 for the full story. Read More
from StreetInsider.com News Articles
Achillion Announces Positive RVR Results With ACH-1625 to Treat Chronic Hepatitis C
March 30, 2011
Once-Daily Dose Achieves 75 - 81% RVR in a Well Tolerated Combination Regimen Read More
from GlobeNewswire News Releases
Hot Stock Movers to watch on Wednesday
March 22, 2011
category FTK , CIEN , LO , and 1 more.
from AC Investor Blog
Hot Stock Movers To Watch On Wednesday
March 22, 2011
( click to enlarge ) Flotek Industries, Inc. (NYSE:FTK) broke out to a new all-time high today accompained by a strong volume suggesting higher levels. The stock has been on a remarkable run since... Read More
category FTK , OCNF , LO , and 10 more.
from DailyMarkets.com
Achillion Granted U.S. Patent for ACH-1625 and Related Protease Inhibitors
March 16, 2011
from GlobeNewswire News Releases
Pre-Open Movers 3/4: (LXU) (LSCC) (WMT) Higher; (BPAX) (MRVL) (GS) Lower
March 04, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6345411 for the full story. Read More
from StreetInsider.com News Articles
After Hours Movers 3/3: (COO) (RSH) Higher; (MRVL) (ACHN) (BSQR) Lower
March 03, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6344210 for the full story. Read More
from StreetInsider.com News Articles
Achillion Pharmaceuticals (ACHN) files $100 million mixed securities shelf
March 03, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6343525 for the full story. Read More
from StreetInsider.com News Articles
Achillion Pharma (ACHN) Posts Narrower than Expected Q4 Loss; Guides FY11 Loss
March 02, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6336559 for the full story. Read More
from StreetInsider.com News Articles
Achillion Reports 2010 Fourth Quarter and Year-End Financial Results
March 02, 2011
from GlobeNewswire News Releases
New Ratings (ACHN, MDRX, ANCB, BWP, CERN, CTSH, CTWS, EEP, EPD, HNSN, MELI, MSEX, RGS, SAP, SWI, STON, SXL)
March 01, 2011
New York, March 1st (TradersHuddle.com) – Following are some of the new analyst ratings before the market open. Research Firms Initiate or Resumed Achillion Pharm. Read More -- Read More
from TradersHuddle.com
Leerink Swann Starts Achillion Pharmaceuticals (ACHN) at Outperform; Attractive Emerging HCV Portfolio
February 28, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6330650 for the full story. Read More
from StreetInsider.com News Articles
Achillion to Present at Upcoming Investor Conferences
February 09, 2011
from GlobeNewswire News Releases
INTT, THLD, MTSL, PSID, ACHN: Biotech Companies Rule the Volatility Field
February 09, 2011
from EmailWire.Com Press Releases
Morning Movers 02/04: SVLF, OPXT, JDSU, AVNW, RPRX, SIMG, CDXS, KNL, OREX Higher; EVBS, PWER, TRGL, CSTR, CPX, BIOD, DLB Lower
February 04, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6260659 for the full story. Read More
from StreetInsider.com News Articles
< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here